• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

    322.90 -8.50 (-2.56%)
    Official Closing Price Updated: 4:15 PM EST, Dec 5, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 603,802
    Open 332.64
    Bid (Size) 315.60 (40)
    Ask (Size) 324.80 (40)
    Prev. Close 331.40
    Today's Range 310.11 - 332.64
    52wk Range 172.67 - 385.22
    Shares Outstanding 1,211,067,023
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
    Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the IRA. 
    Via Investor's Business Daily
    Topics Economy Government
    News headline image
    U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    From BeOne Medicines Ltd.
    Via Business Wire

    Performance

    YTD
    +75.5%
    +75.5%
    1 Month
    +4.4%
    +4.4%
    3 Month
    +1.3%
    +1.3%
    6 Month
    +25.6%
    +25.6%
    1 Year
    +75.5%
    +75.5%

    More News

    Read More
    News headline image
    BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Where BeOne Medicines Stands With Analysts ↗
    Via Benzinga
    News headline image
    Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans ↗
    Via Benzinga
    News headline image
    Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    Analyst Expectations For BeOne Medicines's Future ↗
    Via Benzinga
    News headline image
    BeOne Medicines to Present at Upcoming Investor Conferences
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    Investor Exits $5.5 Million Perpetua Resources Stake Amid Stock's 150% Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    What's Going On With Summit Therapeutics Stock On Monday? ↗
    Via Benzinga
    News headline image
    BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order ↗
    Via Investor's Business Daily
    Topics Government
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio? ↗
    Via Benzinga
    News headline image
    Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients ↗
    Via Benzinga
    News headline image
    Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
    From BeOne Medicines Ltd.
    Via Business Wire

    Frequently Asked Questions

    Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?
    Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.
    What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?
    BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?
    The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market
    What is the current price of BeOne Medicines Ltd. - American Depositary Shares?
    The current price of BeOne Medicines Ltd. - American Depositary Shares is 322.90
    When was BeOne Medicines Ltd. - American Depositary Shares last traded?
    The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 12/05/25 04:15 PM ET
    What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?
    The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 391.05B
    How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?
    BeOne Medicines Ltd. - American Depositary Shares has 391B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.